IDEXX Laboratories, Inc. announced the upcoming launch of the SNAP®? Leish 4Dx®? Test, a comprehensive screening test for vector-borne diseases, including canine leishmaniosis.

The SNAP Leish 4Dx Test uses the trusted SNAP 4Dx Plus testing platform, which detects Lyme disease, heartworm disease, ehrlichiosis, and anaplasmosis. By replacing Lyme disease detection with detection of leishmaniosis, a more prevalent endemic disease in certain regions of the world, the SNAP Leish 4Dx test supports vector-borne disease diagnosis globally. The test will be available in Europe and Asia beginning February 2024.

Leishmaniosis is a potentially fatal zoonotic disease transmitted to dogs by sand flies commonly found in tropical and subtropical regions of Europe, Asia, Africa, and South and Central America. Early detection is key; any dog living in or traveling to these endemic regions is susceptible to infection and should be tested, as the disease can be fatal if left untreated. Infected dogs can remain asymptomatic for months to years, making testing for leishmaniosis an essential component of annual wellness screens.

The launch of the SNAP Leish 4D x Test provides veterinarians with an end-to-end solution for vector-borne disease testing, including: The ability to screen for heartworm disease, ehrichiosis, anaplasmosis, and leishmaniosis with a single sample during the patient visit. Streamlined reference laboratory follow-up testing for quantification of SNAP positives and the opportunity to perform additional follow-up testing in-clinic or at IDEXXReference Laboratories. Compatibility with the SNAP Pro®?

Analyzer, which supports an efficient practice workflow by automatically activating and interpreting test results and facilitating seamless charge capture. Ongoing support and education to keep veterinary staff up-to-date with the latest resources to help protect pets and their families.